{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T21:33:56Z","timestamp":1772141636807,"version":"3.50.1"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2019,7,4]],"date-time":"2019-07-04T00:00:00Z","timestamp":1562198400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,7,4]],"date-time":"2019-07-04T00:00:00Z","timestamp":1562198400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Dig Dis Sci"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1007\/s10620-019-05709-0","type":"journal-article","created":{"date-parts":[[2019,7,4]],"date-time":"2019-07-04T05:59:27Z","timestamp":1562219967000},"page":"3480-3488","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Survey of Nonalcoholic Fatty Liver Disease Knowledge, Nutrition, and Physical Activity Patterns Among the General Public in Beijing, China"],"prefix":"10.1007","volume":"64","author":[{"given":"Stephanie","family":"Chen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Samantha","family":"Chao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Monica","family":"Konerman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huiying","family":"Rao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elizabeth","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andy","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lai","family":"Wei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna S.","family":"Lok","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,7,4]]},"reference":[{"key":"5709_CR1","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1111\/jgh.12036","volume":"28","author":"JG Fan","year":"2013","unstructured":"Fan JG. Epidemiology of alcoholic and nonalcoholic fatty liver disease in China. J Gastroenterol Hepatol. 2013;28:11\u201317.","journal-title":"J Gastroenterol Hepatol"},{"key":"5709_CR2","doi-asserted-by":"publisher","first-page":"383","DOI":"10.3390\/ijerph15020383","volume":"15","author":"J Zhao","year":"2018","unstructured":"Zhao J, Su C, Wang H, Wang Z, Zhang B. New evidence on the effect of medical insurance on the obesity risk of rural residents: findings from the China health and nutrition survey. Int J Environ Res Public Health. 2018;15:383.","journal-title":"Int J Environ Res Public Health"},{"key":"5709_CR3","unstructured":"IDF Western Pacific members. Brussels (Belgium): International Diabetes Federation; 2018. Available at: https:\/\/www.idf.org\/our-network\/regions-members\/western-pacific\/members\/101-china.html . Accessed 1 July 2018."},{"key":"5709_CR4","doi-asserted-by":"crossref","first-page":"e007462","DOI":"10.1161\/JAHA.117.007462","volume":"7","author":"Y Lu","year":"2018","unstructured":"Lu Y, Wang P, Zhou T, et al. Comparison of prevalence, awareness, treatment, and control of cardiovascular risk factors in China and the United States. J Am Heart Assoc. 2018;7:e007462.","journal-title":"J Am Heart Assoc"},{"key":"5709_CR5","doi-asserted-by":"publisher","first-page":"1786","DOI":"10.1111\/j.1440-1746.2009.05914.x","volume":"24","author":"CM Leung","year":"2009","unstructured":"Leung CM, Lai LS, Wong WH, et al. Nonalcoholic fatty liver disease: an expanding problem with low levels of awareness in Hong Kong. J Gastroenterol Hepatol. 2009;24:1786\u20131790.","journal-title":"J Gastroenterol Hepatol"},{"key":"5709_CR6","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1093\/gastro\/gov047","volume":"4","author":"GB Goh","year":"2016","unstructured":"Goh GB, Kwan C, Lim SY, et al. Perceptions of nonalcoholic fatty liver disease\u2014an Asian community-based study. Gastroenterol Rep. 2016;4:131\u2013135.","journal-title":"Gastroenterol Rep"},{"key":"5709_CR7","doi-asserted-by":"publisher","first-page":"4","DOI":"10.3389\/fmed.2014.00004","volume":"1","author":"V Ghevariya","year":"2014","unstructured":"Ghevariya V, Sandar N, Patel K, et al. Knowing what\u2019s out there: awareness of nonalcoholic fatty liver disease. Front Med. 2014;1:4.","journal-title":"Front Med"},{"key":"5709_CR8","doi-asserted-by":"publisher","first-page":"1090","DOI":"10.1056\/NEJMoa0908292","volume":"362","author":"W Yang","year":"2010","unstructured":"Yang W, Lu J, Weng J, et al. Prevalence of diabetes among men and women in China. N Engl J Med. 2010;362:1090\u20131101.","journal-title":"N Engl J Med"},{"key":"5709_CR9","unstructured":"The International Physical Activity Questionnaire (IPAQ)\u2014Short Form; 2001. Available at: http:\/\/www.ipaq.ki.se . Accessed 22 Mar 2017."},{"key":"5709_CR10","unstructured":"Criteria of weight for adults. The National Health and Family Planning Commission of the People\u2019s Republic of China; 2013. Available at: http:\/\/ghdx.healthdata.org\/organizations\/national-health-and-family-planning-commission-china . Accessed 18 Apr 2013."},{"key":"5709_CR11","unstructured":"Guideline for data processing and analysis of the International Physical Activity Questionnaire (IPAQ); 2001. Available at: http:\/\/www.ipaq.ki.se\/scoring.pdf . Accessed 22 Oct 2017."},{"key":"5709_CR12","doi-asserted-by":"publisher","first-page":"3663","DOI":"10.3748\/wjg.v22.i13.3663","volume":"22","author":"ZY Lu","year":"2016","unstructured":"Lu ZY, Shao Z, Li YL, Wulasihan M, Chen XH. Prevalence of and risk factors for nonalcoholic fatty liver disease in a Chinese population: An 8-year follow-up study. World J Gastroenterol. 2016;22:3663\u20133669.","journal-title":"World J Gastroenterol"},{"key":"5709_CR13","doi-asserted-by":"publisher","first-page":"32S","DOI":"10.1016\/j.amjmed.2005.12.021","volume":"119","author":"DT Gold","year":"2006","unstructured":"Gold DT, McClung B. Approaches to patient education: emphasizing the long-term value of compliance and persistence. Am J Med. 2006;119:32S\u201337S.","journal-title":"Am J Med"},{"key":"5709_CR14","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.1016\/j.jhep.2016.07.033","volume":"65","author":"R Pais","year":"2016","unstructured":"Pais R, Barritt AS 4th, Calmus Y, et al. NAFLD and liver transplantation: current burden and expected challenges. J Hepatol. 2016;65:1245\u20131257.","journal-title":"J Hepatol"},{"key":"5709_CR15","doi-asserted-by":"publisher","first-page":"429","DOI":"10.5306\/wjco.v8.i6.429","volume":"8","author":"A Said","year":"2017","unstructured":"Said A, Ghufran A. Epidemic of nonalcoholic fatty liver disease and hepatocellular carcinoma. World J Clin Oncol. 2017;8:429\u2013436.","journal-title":"World J Clin Oncol"},{"key":"5709_CR16","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1210\/er.2012-1009","volume":"34","author":"KH Williams","year":"2013","unstructured":"Williams KH, Shackel NA, Gorrell MD, McLennan SV, Twigg SM. Diabetes and nonalcoholic fatty liver disease: a pathogenic duo. Endocr Rev. 2013;34:84\u2013129.","journal-title":"Endocr Rev"},{"key":"5709_CR17","doi-asserted-by":"publisher","first-page":"1450","DOI":"10.4254\/wjh.v7.i11.1450","volume":"7","author":"M Ahmed","year":"2015","unstructured":"Ahmed M. Nonalcoholic fatty liver disease in 2015. World J Hepatol. 2015;7:1450\u20131459.","journal-title":"World J Hepatol"},{"key":"5709_CR18","doi-asserted-by":"publisher","first-page":"4362","DOI":"10.3748\/wjg.v22.i17.4362","volume":"22","author":"L Mlynarsky","year":"2016","unstructured":"Mlynarsky L, Schlesinger D, Lotan R, et al. Nonalcoholic fatty liver disease is not associated with a lower health perception. World J Gastroenterol. 2016;22:4362\u20134372.","journal-title":"World J Gastroenterol"},{"key":"5709_CR19","doi-asserted-by":"publisher","first-page":"f2907","DOI":"10.1136\/bmj.f2907","volume":"346","author":"JP Block","year":"2013","unstructured":"Block JP, Condon SK, Kleinman K, et al. Consumers\u2019 estimation of calorie content at fast food restaurants: cross sectional observational study. Brit Med J. 2013;346:f2907.","journal-title":"Brit Med J"},{"key":"5709_CR20","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1177\/1557988308327052","volume":"4","author":"CL Harris","year":"2010","unstructured":"Harris CL, George VA. Dietary restraint influences accuracies in estimating energy expenditure and energy intake among physically inactive males. Am J Mens Health. 2010;4:33\u201340.","journal-title":"Am J Mens Health"},{"key":"5709_CR21","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1111\/liv.13302","volume":"37","author":"A Oseini","year":"2017","unstructured":"Oseini A, Sanyal A. Therapies in nonalcoholic steatohepatitis (NASH). Liver Int. 2017;37:97\u2013103.","journal-title":"Liver Int"},{"key":"5709_CR22","doi-asserted-by":"publisher","first-page":"223","DOI":"10.2147\/DMSO.S95299","volume":"10","author":"E Hendricks","year":"2017","unstructured":"Hendricks E. Off-label drugs for weight management. Diabetes Metab Syndr Obes. 2017;10:223\u2013234.","journal-title":"Diabetes Metab Syndr Obes"},{"key":"5709_CR23","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1007\/s11901-018-0409-7","volume":"17","author":"J Walter","year":"2018","unstructured":"Walter J, Navarro V, Rossi S. Drug-induced liver injury associated with weight loss supplements. Curr Hepatol Rep. 2018;17:245\u2013253.","journal-title":"Curr Hepatol Rep"}],"container-title":["Digestive Diseases and Sciences"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-019-05709-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10620-019-05709-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-019-05709-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,22]],"date-time":"2022-09-22T22:15:52Z","timestamp":1663884952000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10620-019-05709-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7,4]]},"references-count":23,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["5709"],"URL":"https:\/\/doi.org\/10.1007\/s10620-019-05709-0","relation":{},"ISSN":["0163-2116","1573-2568"],"issn-type":[{"value":"0163-2116","type":"print"},{"value":"1573-2568","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,7,4]]},"assertion":[{"value":"20 March 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 June 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 July 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"Anna Lok has received research funding from BMS, Gilead, and TARGET Pharma and serves as an advisor\/consultant for Gilead, Reseverlogix, Roche, Spring Bank, and Viravaxx. Lai Wei receives research funding from Abbvie and BMS and serves as an advisor\/consultant for Abbvie, Ascletis, BMS, Gilead, and MSD. Stephanie Chen, Samantha Chao, Monica Konerman, Wei Zhang, Huiying Rao, Elizabeth Wu, and Andy Lin declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures performed involving human participants were in accordance with the ethical standards of the institutional research committees of University of Michigan and Peking University and with the 1964 Declaration of Helsinki and its later amendments or comparable ethical standards. This article does not contain any studies with animals performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}